Skip to content
10-Q

Quarterly Report

America Great Health

0001185185-24-000606

← back to feed
Filed
Jun 3, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2024 · Mar 31, 2024 21.17B sh
Shares Diluted Q3 2024 · Mar 31, 2023 21.09B sh
Shares Outstanding Q3 2024 · Mar 31, 2024 21.19B sh
Capex Q3 2024 · Mar 31, 2024 $0
Capex Q3 2024 · Mar 31, 2023 $44.42K
Long Term Debt Q3 2024 · Mar 31, 2024 $1.12M
Long Term Debt Q3 2024 · Jun 30, 2023 $1.12M
Short Term Debt Q3 2024 · Mar 31, 2024 $714.36K
Short Term Debt Q3 2024 · Jun 30, 2023 $705.22K
Stockholders Equity Q3 2024 · Mar 31, 2024 −$4.8M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$4.45M
Current Liabilities Q3 2024 · Mar 31, 2024 $3.25M
Current Liabilities Q3 2024 · Jun 30, 2023 $3.09M
Total Liabilities Q3 2024 · Mar 31, 2024 $5.21M
Total Liabilities Q3 2024 · Jun 30, 2023 $4.82M
Current Assets Q3 2024 · Mar 31, 2024 $266.27K
Current Assets Q3 2024 · Jun 30, 2023 $179.47K
Total Assets Q3 2024 · Mar 31, 2024 $333.39K
Total Assets Q3 2024 · Jun 30, 2023 $299.13K
Stock Issued Q3 2024 · Jan 16, 2024 1.5M sh
Stock Issued Q3 2024 · Mar 31, 2022 1.3M sh
Operating Cash Flow restated Q3 2024 · Mar 31, 2023 −$417.92K
Eps Diluted Q3 2024 · Mar 31, 2023 $0.00
Eps Basic Q3 2024 · Mar 31, 2023 $0.00
Sga Expense Q3 2024 · Mar 31, 2023 $151K
Sga Expense Q3 2024 · Mar 31, 2023 $428.99K
Net Income restated Q3 2024 · Mar 31, 2023 −$212.73K
Net Income restated Q3 2024 · Mar 31, 2023 −$519.63K
Operating Income Q3 2024 · Mar 31, 2023 −$111.73K
Operating Income Q3 2024 · Mar 31, 2023 −$335.06K
Gross Profit Q3 2024 · Mar 31, 2023 $39.26K
Gross Profit Q3 2024 · Mar 31, 2023 $93.93K
Cost Of Revenue Q3 2024 · Mar 31, 2023 $190
Cost Of Revenue Q3 2024 · Mar 31, 2023 $35.69K